HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): James D. Luketich Nael Martini Robert J. Ginsberg Michael E. Burt Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luketich, J. D. Articles by Burt, M. E. Search for Related Content PubMed PubMed Citation Articles by Luketich, J. D. Articles by Burt, M. E.

Ann Thorac Surg 1995;60:1609-1611
© 1995 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Successful Treatment of Solitary Extracranial Metastases From Non-Small Cell Lung Cancer

Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

Accepted for publication July 27, 1995.

Background. Recurrence after resection of non-small cell lung carcinoma is generally associated with a poor outcome and is treated with either systemic agents or palliative irradiation. Recently, long-term survival has been reported after resection of isolated brain metastases from non-small cell lung carcinoma, but resection of other metastatic sites has not been explored fully.

Methods. We have identified 14 patients who had solitary extracranial metastases treated aggressively after curative treatment of their non-small cell lung carcinoma. The histology was squamous carcinoma in 5, adenocarcinoma in 8, and large cell carcinoma in 1. Initially, 3 patients had stage I, 5 stage II, and 6 stage IIIa disease.

Results. The sites of metastases included extrathoracic lymph nodes (six), skeletal muscle (four), bone (three), and small bowel (one). The median disease-free interval before metastases was 19.5 months (range, 5 to 71 months). Complete surgical resection of the metastatic site was the treatment in 12 of 14 patients. Two patients received only curative irradiation to the metastatic site, with complete response. The overall 10-year actuarial survival (Kaplan-Meier) was 86%. To date, 11 patients are alive and well after treatment of their metastases (17 months to 13 years), 1 has recurrent disease, 1 died of recurrent widespread metastases, and 2 died of unrelated causes.

Conclusion. Long-term survival is possible after treatment of isolated metastases to various sites from non-small cell lung carcinoma, but patient selection is critical.

This article has been cited by other articles:

				H. Sugimura, F. C. Nichols, P. Yang, M. S. Allen, S. D. Cassivi, C. Deschamps, B. A. Williams, and P. C. Pairolero Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection Ann. Thorac. Surg., February 1, 2007; 83(2): 409 - 418. [Abstract] [Full Text] [PDF]

				T. Hishida, K. Nagai, J. Yoshida, M. Nishimura, G.-i. Ishii, M. Iwasaki, and Y. Nishiwaki Is surgical resection indicated for a solitary non-small cell lung cancer recurrence? J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 838 - 842. [Abstract] [Full Text] [PDF]

				V. Ambrogi, G. Tonini, and T. C. Mineo Prolonged Survival After Extracranial Metastasectomy From Synchronous Resectable Lung Cancer Ann. Surg. Oncol., September 1, 2001; 8(8): 663 - 666. [Abstract] [Full Text] [PDF]

				H. Porte, J. Siat, B. Guibert, F. Lepimpec-Barthes, R. Jancovici, A. Bernard, A. Foucart, and A. Wurtz Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Ann. Thorac. Surg., March 1, 2001; 71(3): 981 - 985. [Abstract] [Full Text] [PDF]